Analysis of induced sputum in adults with asthma: identification of subgroup with isolated sputum neutrophilia and poor response to inhaled corticosteroids (2024)

. 2002 Oct;57(10):875–879. doi: 10.1136/thorax.57.10.875

R Green

Abstract

Background: The debate as to whether asthma is a single or heterogeneous disease remains unresolved although pathological studies, mostly using fibreoptic bronchoscopy on small numbers of subjects, have emphasised the similarities between different clinical phenotypes.

Methods: Lower airway inflammation was assessed non-invasively using induced sputum in 34 normal controls and 259 adults with symptomatic asthma receiving treatment at steps 1–3 of the British Thoracic Society (BTS) guidelines. A subgroup of 49 patients treated with as required ß₂ agonists only who met BTS criteria for a step up in treatment were studied before and 2 months after treatment with inhaled budesonide 400 µg twice daily.

Results: There was considerable heterogeneity in induced sputum cell counts, particularly in non-atopic patients. A subgroup of 60 patients had a distinctive sputum cell profile with a neutrophil count higher than our normal range (>65.3%) and a normal sputum eosinophil count (<1.9%). These patients were older, predominantly female, and were more likely to be non-atopic but otherwise had similar clinical and physiological features to the group as a whole. Among the 49 subjects studied before and after inhaled budesonide, 11 patients had an isolated sputum neutrophilia. Following treatment, these patients showed significantly less improvement in visual analogue symptom scores (–5.5 v –19.4 mm; mean difference 13.9; 95% CI 0.7 to 27.0), forced expiratory volume in 1 second (FEV₁) (–0.08 v 0.13 l; mean difference 0.21; 95% CI 0.03 to 0.39), and concentration of methacholine provoking a fall in FEV₁ of 20% or more (PC₂₀) (0.15 v 1.29 doubling doses; mean difference 1.11; 95% CI 0.13 to 2.15) than the remaining 38 patients.

Conclusions: These results suggest the presence of a distinct subgroup of patients with mild to moderate asthma who have predominantly neutrophilic airway inflammation and who respond less well to treatment with inhaled corticosteroids.

Full Text

The Full Text of this article is available as a PDF (134.8 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

Aas K. Heterogeneity of bronchial asthma. Sub-populations--or different stages of the disease. Allergy. 1981 Jan;36(1):3–14. doi: 10.1111/j.1398-9995.1981.tb01818.x. [DOI] [PubMed] [Google Scholar]
Adelroth E., Rosenhall L., Johansson S. A., Linden M., Venge P. Inflammatory cells and eosinophilic activity in asthmatics investigated by bronchoalveolar lavage. The effects of antiasthmatic treatment with budesonide or terbutaline. Am Rev Respir Dis. 1990 Jul;142(1):91–99. doi: 10.1164/ajrccm/142.1.91. [DOI] [PubMed] [Google Scholar]
Belda J., Leigh R., Parameswaran K., O'Byrne P. M., Sears M. R., Hargreave F. E. Induced sputum cell counts in healthy adults. Am J Respir Crit Care Med. 2000 Feb;161(2 Pt 1):475–478. doi: 10.1164/ajrccm.161.2.9903097. [DOI] [PubMed] [Google Scholar]
Bentley A. M., Durham S. R., Kay A. B. Comparison of the immunopathology of extrinsic, intrinsic and occupational asthma. J Investig Allergol Clin Immunol. 1994 Sep-Oct;4(5):222–232. [PubMed] [Google Scholar]
Bentley A. M., Menz G., Storz C., Robinson D. S., Bradley B., Jeffery P. K., Durham S. R., Kay A. B. Identification of T lymphocytes, macrophages, and activated eosinophils in the bronchial mucosa in intrinsic asthma. Relationship to symptoms and bronchial responsiveness. Am Rev Respir Dis. 1992 Aug;146(2):500–506. doi: 10.1164/ajrccm/146.2.500. [DOI] [PubMed] [Google Scholar]
Brightling C. E., Monterio W., Green R. H., Parker D., Morgan M. D., Wardlaw A. J., Pavord D. Induced sputum and other outcome measures in chronic obstructive pulmonary disease: safety and repeatability. Respir Med. 2001 Dec;95(12):999–1002. doi: 10.1053/rmed.2001.1195. [DOI] [PubMed] [Google Scholar]
Claman D. M., Boushey H. A., Liu J., Wong H., Fahy J. V. Analysis of induced sputum to examine the effects of prednisone on airway inflammation in asthmatic subjects. J Allergy Clin Immunol. 1994 Nov;94(5):861–869. doi: 10.1016/0091-6749(94)90154-6. [DOI] [PubMed] [Google Scholar]
Crimi E., Spanevello A., Neri M., Ind P. W., Rossi G. A., Brusasco V. Dissociation between airway inflammation and airway hyperresponsiveness in allergic asthma. Am J Respir Crit Care Med. 1998 Jan;157(1):4–9. doi: 10.1164/ajrccm.157.1.9703002. [DOI] [PubMed] [Google Scholar]
Fahy J. V., Kim K. W., Liu J., Boushey H. A. Prominent neutrophilic inflammation in sputum from subjects with asthma exacerbation. J Allergy Clin Immunol. 1995 Apr;95(4):843–852. doi: 10.1016/s0091-6749(95)70128-1. [DOI] [PubMed] [Google Scholar]
Folkard S. G., Westwick J., Millar A. B. Production of interleukin-8, RANTES and MCP-1 in intrinsic and extrinsic asthmatics. Eur Respir J. 1997 Sep;10(9):2097–2104. doi: 10.1183/09031936.97.10092097. [DOI] [PubMed] [Google Scholar]
Gibson P. G., Simpson J. L., Saltos N. Heterogeneity of airway inflammation in persistent asthma : evidence of neutrophilic inflammation and increased sputum interleukin-8. Chest. 2001 May;119(5):1329–1336. doi: 10.1378/chest.119.5.1329. [DOI] [PubMed] [Google Scholar]
Hoskins G., McCowan C., Neville R. G., Thomas G. E., Smith B., Silverman S. Risk factors and costs associated with an asthma attack. Thorax. 2000 Jan;55(1):19–24. doi: 10.1136/thorax.55.1.19. [DOI] [PMC free article] [PubMed] [Google Scholar]
Humbert M., Durham S. R., Ying S., Kimmitt P., Barkans J., Assoufi B., Pfister R., Menz G., Robinson D. S., Kay A. B. IL-4 and IL-5 mRNA and protein in bronchial biopsies from patients with atopic and nonatopic asthma: evidence against "intrinsic" asthma being a distinct immunopathologic entity. Am J Respir Crit Care Med. 1996 Nov;154(5):1497–1504. doi: 10.1164/ajrccm.154.5.8912771. [DOI] [PubMed] [Google Scholar]
Humbert M., Menz G., Ying S., Corrigan C. J., Robinson D. S., Durham S. R., Kay A. B. The immunopathology of extrinsic (atopic) and intrinsic (non-atopic) asthma: more similarities than differences. Immunol Today. 1999 Nov;20(11):528–533. doi: 10.1016/s0167-5699(99)01535-2. [DOI] [PubMed] [Google Scholar]
Humbert M., Ying S., Corrigan C., Menz G., Barkans J., Pfister R., Meng Q., Van Damme J., Opdenakker G., Durham S. R. Bronchial mucosal expression of the genes encoding chemokines RANTES and MCP-3 in symptomatic atopic and nonatopic asthmatics: relationship to the eosinophil-active cytokines interleukin (IL)-5, granulocyte macrophage-colony-stimulating factor, and IL-3. Am J Respir Cell Mol Biol. 1997 Jan;16(1):1–8. doi: 10.1165/ajrcmb.16.1.8998072. [DOI] [PubMed] [Google Scholar]
Hunter C. J., Ward R., Woltmann G., Wardlaw A. J., Pavord I. D. The safety and success rate of sputum induction using a low output ultrasonic nebuliser. Respir Med. 1999 May;93(5):345–348. doi: 10.1016/s0954-6111(99)90317-7. [DOI] [PubMed] [Google Scholar]
Jatakanon A., Uasuf C., Maziak W., Lim S., Chung K. F., Barnes P. J. Neutrophilic inflammation in severe persistent asthma. Am J Respir Crit Care Med. 1999 Nov;160(5 Pt 1):1532–1539. doi: 10.1164/ajrccm.160.5.9806170. [DOI] [PubMed] [Google Scholar]
Lim S., Jatakanon A., John M., Gilbey T., O'connor B. J., Chung K. F., Barnes P. J. Effect of inhaled budesonide on lung function and airway inflammation. Assessment by various inflammatory markers in mild asthma. Am J Respir Crit Care Med. 1999 Jan;159(1):22–30. doi: 10.1164/ajrccm.159.1.9706006. [DOI] [PubMed] [Google Scholar]
Pavord I. D., Brightling C. E., Woltmann G., Wardlaw A. J. Non-eosinophilic corticosteroid unresponsive asthma. Lancet. 1999 Jun 26;353(9171):2213–2214. doi: 10.1016/S0140-6736(99)01813-9. [DOI] [PubMed] [Google Scholar]
Pavord I. D., Pizzichini M. M., Pizzichini E., Hargreave F. E. The use of induced sputum to investigate airway inflammation. Thorax. 1997 Jun;52(6):498–501. doi: 10.1136/thx.52.6.498. [DOI] [PMC free article] [PubMed] [Google Scholar]
Pizzichini E., Pizzichini M. M., Efthimiadis A., Evans S., Morris M. M., Squillace D., Gleich G. J., Dolovich J., Hargreave F. E. Indices of airway inflammation in induced sputum: reproducibility and validity of cell and fluid-phase measurements. Am J Respir Crit Care Med. 1996 Aug;154(2 Pt 1):308–317. doi: 10.1164/ajrccm.154.2.8756799. [DOI] [PubMed] [Google Scholar]
Rosi E., Ronchi M. C., Grazzini M., Duranti R., Scano G. Sputum analysis, bronchial hyperresponsiveness, and airway function in asthma: results of a factor analysis. J Allergy Clin Immunol. 1999 Feb;103(2 Pt 1):232–237. doi: 10.1016/s0091-6749(99)70496-3. [DOI] [PubMed] [Google Scholar]
Spanevello A., Confalonieri M., Sulotto F., Romano F., Balzano G., Migliori G. B., Bianchi A., Michetti G. Induced sputum cellularity. Reference values and distribution in normal volunteers. Am J Respir Crit Care Med. 2000 Sep;162(3 Pt 1):1172–1174. doi: 10.1164/ajrccm.162.3.9908057. [DOI] [PubMed] [Google Scholar]
Tang C., Rolland J. M., Ward C., Quan B., Walters E. H. IL-5 production by bronchoalveolar lavage and peripheral blood mononuclear cells in asthma and atopy. Eur Respir J. 1997 Mar;10(3):624–632. [PubMed] [Google Scholar]
Wenzel S. E., Schwartz L. B., Langmack E. L., Halliday J. L., Trudeau J. B., Gibbs R. L., Chu H. W. Evidence that severe asthma can be divided pathologically into two inflammatory subtypes with distinct physiologic and clinical characteristics. Am J Respir Crit Care Med. 1999 Sep;160(3):1001–1008. doi: 10.1164/ajrccm.160.3.9812110. [DOI] [PubMed] [Google Scholar]